Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,903 | -13,557 | -30,439 | -21,162 | -12,658 |
| Depreciation Amortization | N/A | 11 | 47 | 35 | 23 |
| Accounts payable and accrued liabilities | 2,543 | -865 | 1,384 | 1,231 | -617 |
| Other Working Capital | -1,172 | 1,746 | 3,615 | 5,048 | 873 |
| Other Operating Activity | -2,751 | 1,553 | 1,933 | 1,118 | 2,022 |
| Operating Cash Flow | $-5,283 | $-11,112 | $-23,460 | $-13,730 | $-10,357 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 10,897 | -15,124 | 12,759 | 6,759 |
| PPE Investments | N/A | N/A | -2 | N/A | N/A |
| Investing Cash Flow | $N/A | $10,897 | $-15,126 | $12,759 | $6,759 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 45,648 | 45,648 | N/A |
| Other Financing Activity | 1,100 | -643 | -156 | -156 | -156 |
| Financing Cash Flow | $1,100 | $-643 | $45,492 | $45,492 | $-156 |
| Beginning Cash Position | 10,188 | 15,816 | 8,910 | 8,910 | 8,910 |
| End Cash Position | 6,005 | 14,958 | 15,816 | 53,431 | 5,156 |
| Net Cash Flow | $-4,183 | $-858 | $6,906 | $44,521 | $-3,754 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,283 | -11,112 | -23,460 | -13,730 | -10,357 |
| Capital Expenditure | N/A | N/A | -2 | N/A | N/A |
| Free Cash Flow | -5,283 | -11,112 | -23,462 | -13,730 | -10,357 |